Equillium, Inc.
EQ- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001746466
No open-market purchases or sales by Equillium, Inc. insiders were filed in the last 90 days; 60 institutions reported holding it in 13F filings for Q2 2026, worth $133.0M in total; no superinvestor holds it.
13F holders, Q4 2023
Institutional positions in Equillium, Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 25
- +1 vs. Q3 2023
- Shares held
- 9.48M
- +4.80M (+102.8%) vs. Q3 2023
- Total value
- $6.85M
- +$3.39M (+98.0%) vs. Q3 2023
- New holders
- 6
- 4 more added
- Sold out
- 5
- 6 more reduced
1 institution that held it in Q3 2023 haven't filed for Q4 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting EQ on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 60 | $133.0M |
| Q1 2026 | 50 | $81.0M |
| Q4 2025 | 36 | $54.7M |
| Q3 2025 | 40 | $42.4M |
| Q2 2025 | 27 | $2.74M |
| Q1 2025 | 24 | $3.39M |
| Q4 2024 | 26 | $6.52M |
| Q3 2024 | 26 | $7.25M |
| Q2 2024 | 25 | $6.15M |
| Q1 2024 | 28 | $20.5M |
| Q4 2023 | 25 | $6.85M |
| Q3 2023 | 25 | $6.75M |
| Q2 2023 | 27 | $7.44M |
| Q1 2023 | 28 | $7.86M |
| Q4 2022 | 31 | $13.3M |
| Q3 2022 | 30 | $28.4M |
| Q2 2022 | 25 | $25.6M |
| Q1 2022 | 30 | $39.7M |
| Q4 2021 | 26 | $27.0M |
| Q3 2021 | 22 | $49.9M |
| Q2 2021 | 28 | $41.9M |
| Q1 2021 | 33 | $54.6M |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding Equillium, Inc.; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Royal Bank of Canada | 143 | $0 | 0.00% | −156−52.2% | Reduced |
| Bank of America Corp | 12 | $9 | 0.00% | +12 | New |
| Group One Trading, L.P. | 200 | $145 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 1,149 | $831 | 0.00% | +10+0.9% | Added |
| BlackRock Inc. | 3,823 | $2.76K | 0.00% | −6,003−61.1% | Reduced |
| ADAR1 Capital Management, LLC | 6,500 | $4.70K | 0.00% | +6,500 | New |
| Tower Research Capital LLC (TRC) | 9,382 | $6.78K | 0.00% | −510−5.2% | Reduced |
| Jane Street Group, LLC | 12,040 | $8.71K | 0.00% | +12,040 | New |
| Capital CS Group, LLC | 19,000 | $13.7K | 0.02% | 00.0% | Unchanged |
| Millennium Management LLC | 24,692 | $17.9K | 0.00% | −1,146−4.4% | Reduced |
| Northern Trust Corp | 35,155 | $25.4K | 0.00% | 00.0% | Unchanged |
| Integrated Wealth Concepts LLC | 40,000 | $28.9K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 56,220 | $40.6K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 62,999 | $45.5K | 0.00% | +16,016+34.1% | Added |
| Prudential Financial Inc | 65,400 | $47.3K | 0.00% | +7,600+13.1% | Added |
| Commonwealth Equity Services, LLC | 100,000 | $72.0K | 0.00% | +100,000 | New |
| Callan Capital, LLC | 99,688 | $72.1K | 0.01% | −4,000−3.9% | Reduced |
| Geode Capital Management, LLC | 172,387 | $124.7K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 347,500 | $251.0K | 0.00% | +54,209+18.5% | Added |
| JPMorgan Chase & Co | 350,031 | $253.1K | 0.00% | −523,578−59.9% | Reduced |
| Tang Capital Management LLC | 400,000 | $289.2K | 0.03% | 00.0% | Unchanged |
| Cota Capital Management, LLC | 562,278 | $406.5K | 0.17% | 00.0% | Unchanged |
| Vanguard Group Inc | 836,930 | $605.1K | 0.00% | 00.0% | Unchanged |
| Takeda Pharmaceutical Co Ltd | 1,824,977 | $1.31M | 0.40% | +1,824,977 | New |
| Decheng Capital LLC | 4,447,308 | $3.22M | 0.90% | +4,447,308 | New |
| Franklin Resources Inc | 0 | $0 | 0.00% | −895,000−100.0% | Sold out |
| Bridgeway Capital Management, LLC | 0 | $0 | 0.00% | −125,500−100.0% | Sold out |
| DCF Advisers, LLC | 0 | $0 | 0.00% | −69,871−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −36,287−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −2,073−100.0% | Sold out |
| Decheng Capital Management III (Cayman), LLC | – | – | – | – | Not filed |